<p>Participant Demographics and Current/Lifetime Drug Use, Percent (N) or Mean (SEM).</p
<p>Demographic and clinical data of participants according to the level of medication adherence (N =...
Demographics of participants who completed all study procedures, overall and by group assignment.</p
<p>Participant demographic information is presented in <a href="http://www.plosone.org/article/info:...
<p>Characteristics of all participants, and participants grouped by lifetime synthetic drug use.</p
Healthcare utilisation in each cohort summarised by participant characteristics.</p
Sociodemographic and clinical characteristics of the study participants, n (%).</p
a<p>Mean (SD).</p>b<p>Including students.</p>c<p>Standardized mean difference.</p
<p>Clinical characteristics of the subjects presented as numbers (%) or mean (SD).</p
<p>“Use in last 30 days” indicates number of days of drug use in the 30 days preceding entry into th...
<p>Demographic and clinical information of study participants (N = 3491) (n, %).</p
<p>Data presented as mean (SD) or number (%)</p><p>Characteristics of study participants.</p
Summary of demographic characteristics of study participants across drug types.</p
<p>Raven IQ, IQ measured by means of the Raven Progressive Matrices; Monthly drinks, monthly number ...
<p>The Demographics and Clinical Characteristics of the Baseline Participants.</p
<p>Demographic and clinical characteristics of participants at baseline, mean (standard deviation).<...
<p>Demographic and clinical data of participants according to the level of medication adherence (N =...
Demographics of participants who completed all study procedures, overall and by group assignment.</p
<p>Participant demographic information is presented in <a href="http://www.plosone.org/article/info:...
<p>Characteristics of all participants, and participants grouped by lifetime synthetic drug use.</p
Healthcare utilisation in each cohort summarised by participant characteristics.</p
Sociodemographic and clinical characteristics of the study participants, n (%).</p
a<p>Mean (SD).</p>b<p>Including students.</p>c<p>Standardized mean difference.</p
<p>Clinical characteristics of the subjects presented as numbers (%) or mean (SD).</p
<p>“Use in last 30 days” indicates number of days of drug use in the 30 days preceding entry into th...
<p>Demographic and clinical information of study participants (N = 3491) (n, %).</p
<p>Data presented as mean (SD) or number (%)</p><p>Characteristics of study participants.</p
Summary of demographic characteristics of study participants across drug types.</p
<p>Raven IQ, IQ measured by means of the Raven Progressive Matrices; Monthly drinks, monthly number ...
<p>The Demographics and Clinical Characteristics of the Baseline Participants.</p
<p>Demographic and clinical characteristics of participants at baseline, mean (standard deviation).<...
<p>Demographic and clinical data of participants according to the level of medication adherence (N =...
Demographics of participants who completed all study procedures, overall and by group assignment.</p
<p>Participant demographic information is presented in <a href="http://www.plosone.org/article/info:...
DOI
Add to ORKG